OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients — Stella

Recruiting

Back to Cutaneous Leishmaniases trials

Trial locations(1 site)

Ethiopia

Africa Leprosy, Tuberculosis, Rehabilitation and Training (ALERT) Hospital, Addis Ababa

Key details

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

Alert Hospital, Ethiopia, Armauer Hansen Research Institute, Ethiopia

Enrollment target

~80 participants

Started

June 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

2 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov